Stellar Biotechnologies Featured in United Academics Magazine
Stellar Biotechnologies is featured this week in an online article at the United Academics Magazine website
The story highlights the importance of KLH as a cancer vaccine carrier, and includes recognition to Stellar for our role in pioneering sustainable KLH manufacturing.
A popular use for KLH is as a carrier protein for the new classes of therapeutic vaccines being developed to treat cancer, infectious diseases, and immune disorders. Stellar’s business model includes capitalizing on the growing commercial demand for KLH by those pharmaceutical companies and vaccine developers.